CIM
HAE icon

CIM Investment Management’s Haemonetics HAE Stock Holding History

CIM Investment Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3,298
Closed -$329K – 260
2020
Q1 		$329K Buy
3,298
+924
+39% +$100K 0.16% 127
2019
Q4 		$273K Buy
2,374
+155
+7% +$18.8K 0.11% 167
2019
Q3 		$280K Buy
+2,219
New +$282K 0.1% 247
2019
Q2 		– Sell
-8,038
Closed -$703K – 328
2019
Q1 		$703K Buy
8,038
+1,721
+27% +$157K 0.27% 76
2018
Q4 		$632K Buy
6,317
+1,564
+33% +$164K 0.27% 74
2018
Q3 		$545K Buy
+4,753
New +$492K 0.19% 136

Other funds holding HAE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIM Investment Management's HAE Position: Q2 2020 in Review

CIM Investment Management sold out of Haemonetics (HAE) in Q2 2020, closing a stake of 3,298 shares — an estimated $329K sold.

CIM Investment Management first reported a position in HAE in Q3 2018 and held it in 6 quarters. The position peaked at $703K in Q1 2019. 285 funds tracked by Wall St. Rank hold HAE as of Q2 2020.

  • CIM Investment Management reported no remaining Haemonetics position as of Q2 2020 after selling out during the quarter.
  • CIM Investment Management sold 3,298 Haemonetics shares in Q2 2020, an estimated $329K.
  • CIM Investment Management first reported a position in Haemonetics in Q3 2018 and held it in 6 quarters.
  • CIM Investment Management's Haemonetics position peaked at $703K in Q1 2019.
  • 285 funds tracked by Wall St. Rank held Haemonetics as of Q2 2020.

Based on CIM Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.